Moleculin Biotech, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Moleculin Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Moleculin Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Moleculin Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4.65M.
  • Moleculin Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$23K, a 100% decline from 2021.
  • Moleculin Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $74.7M, a 231% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.65M +$4.67M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-22
2022 -$23K -$74.7M -100% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-22
2021 $74.7M +$52.2M +231% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $22.5M +$1.7M +8.13% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 $20.9M +$8.81M +73.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-24
2018 $12M +$1.99M +19.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-19
2017 $10.1M +$1.19M +13.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-21
2016 $8.87M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.